| 常用名 | Pasireotide diaspartate | CAS号 | 820232-50-6 |
|---|---|---|---|
| 价格 | ¥需询单/100mg ¥需询单/250mg ¥需询单/500mg | 纯度 | 98.0% |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. 物理化学性质: CAS号:820232-50-6 常用中文名:Pasireotide diaspartate 常用英文名:Pasireotide diaspartate 分子式:C66H80N12O17 分子量:1313.412 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |